May. 22 at 6:13 PM
$SLS 60th Event Launched the Share Price - Because the IDMC Unblinded Actual Phase 3 MOS and IR Data - ACTUAL MOS and IR DATA that Told Most Industry Players GPS is GOLDEN.
$ABBV KNOWS.
- The 72nd Event PR ALSO Launched the Share Price
- The 78th Event PR ALSO Launched the Share Price
• the Imminent 80th and FINAL Event PR - will Absolutely Send this - stratospheric - BALLISTIC VERTICALITY.
• 80th Event PR is coming. It is Imminent and Inevitable.
- 26 + months ranging up to 64 months, Events are NOT LINEAR.
Easily could see a rapid spate of 2 or 3 Events in a given month.
The Registrational Phase 3 Results will Give Gps the FDA Green light to treat Upwards of 50,000 AML Remission Patients each year + another 100,000 Right Now Currently IN REMISSION who'll Immediately benefit from Gps Immunotherapy.
$28B + Total Addressable Market.
This Puny
$1.47B Mcap is instantly worth
$40B + the moment the Market Sees the Pha 3 Results.
-
$ABVX from
$5 /
$270M Mcap to
$148 /
$12.5B
